Exciting times are comming! proud graduates of SHAAR Healthcare Innovation Hub
#LungCancer takes more lives each year than any other cancer, with over 2 million cases diagnosed annually (World Health Organization). SHAAR’s #MedTech program is driving innovation to meet this global health crisis, supporting groundbreaking startups that deliver real impact. Snipe Medical, a graduate of #SHAARMedTech, is transforming lung cancer care with its minimally invasive IRE (Irreversible Electroporation) ablation technology. This innovative approach offers safer, less invasive treatment options that reduce risks and recovery time for patients. Ben Omri, CEO of Snipe Medical, shared: “SHAAR has been a valuable experience, offering practical insights and connections that truly accelerated our journey in #healthTech. We’re grateful for the opportunity to be part of such a focused and impactful program.” With their exciting clinical plans and preparations underway for the next phase of growth, Snipe Medical is making strides toward reshaping #oncology care globally. Discover how SHAAR empowers startups to shape the future of #healthcare: https://lnkd.in/dcDdmbrA #HealthcareInnovation #LungCancerTreatment #ClinicalTrials #SHAARScaleup #InvestingInInnovation #SHAARhealthcare Arieli Capital | Shaare Zedek Medical Center, Jerusalem | Shaare Zedek Scientific (Madait) | Nurit Kantarovitch | Renana Ofan | Ben Omri